Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Oxurion Eyes $12bn Opportunity After Restructuring
New CEO Completes Strategic Review
Jun 25 2021
•
By
Kevin Grogan
Retinal vascular diseases represent a huge market opportunity • Source: Archive
More from Sensory
More from Therapy Areas